William D. Hedrich
Impact in
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
-
- HER2/EGFR in Cancer Research
- Drug Transport and Resistance Mechanisms
- CAR-T cell therapy research
Papers in
- Oncology 7
- Drug Transport and Resistance Mechanisms 2
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Hazem E. Hassan (3 shared papers)Hongbing Wang (3 shared papers)Tamer E. Fandy (1 shared paper)Hossam M. Ashour (1 shared paper)Robert Gharavi (1 shared paper)Scott Heyward (2 shared papers)Audra L. Stinchcomb (1 shared paper)Abhay Andar (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Pharmaceutical Research (2 papers)Molecular Pharmaceutics (1 paper)Toxicology (1 paper)European Journal of Medicinal Chemistry (1 paper)
- Partner nations
- United StatesSpainGermany
In The Last Decade
William D. Hedrich
11 papers receiving 266 citations
Peers
Comparison fields: 5 of 72
- Pharmacology 70
- Oncology 93
- Anesthesiology and Pain Medicine 10
- Radiology, Nuclear Medicine and Imaging 42
- Toxicology 4
Countries citing papers authored by William D. Hedrich
This map shows the geographic impact of William D. Hedrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William D. Hedrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William D. Hedrich more than expected).
Fields of papers citing papers by William D. Hedrich
This network shows the impact of papers produced by William D. Hedrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William D. Hedrich. The network helps show where William D. Hedrich may publish in the future.
Co-authors
The 25 scholars most cited alongside William D. Hedrich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 111 | |
| 2 | 2017 | 69 | |
| 3 | 2016 | 17 | |
| 4 | 2015 | 17 | |
| 5 | 2017 | 16 | |
| 6 | 2020 | 14 | |
| 7 | 2019 | 11 | |
| 8 | 2021 | 7 | |
| 9 | 2020 | 5 | |
| 10 | 2024 | 2 | |
| 11 | 2024 | 1 | |
| 12 | 2025 | 0 | |
| 13 | 2024 | 0 |
About William D. Hedrich
William D. Hedrich is a scholar working on Oncology, Molecular Biology, Pediatrics, Perinatology and Child Health, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine, having authored 13 papers that have together received 270 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (2 papers), Acute Lymphoblastic Leukemia research (2 papers), Childhood Cancer Survivors' Quality of Life (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Pharmacological Effects and Toxicity Studies (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). The work is most often cited by research in Pharmacology (70 citations), Oncology (93 citations), Anesthesiology and Pain Medicine (10 citations), Radiology, Nuclear Medicine and Imaging (42 citations) and Toxicology (4 citations). William D. Hedrich has collaborated with scholars based in United States, Spain and Germany. Frequent co-authors include Hazem E. Hassan, Hongbing Wang, Tamer E. Fandy, Hossam M. Ashour, Hongbing Wang, Robert Gharavi, Scott Heyward, Audra L. Stinchcomb, Abhay Andar and Jingwei Xiao. Their work appears in journals such as Journal of Clinical Oncology, Pharmaceutical Research, Molecular Pharmaceutics, Toxicology and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.